{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-010995","form_type":"8-K","ticker":"ANIX","cik":"0000715446","company_name":"Anixa Biosciences Inc","filed_at":"2024-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.730307+00:00","generated_at":"2026-06-04T09:22:10.624868+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Anixa Biosciences re-elects four directors and ratifies auditor at 2024 annual meeting","bullets":["Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. re-elected as directors with 7.9M-7.7M votes for.","Executive compensation approved on non-binding advisory basis: 6.0M for, 1.8M against, 123K abstain.","Haskell & White LLP ratified as independent auditor for FY ending Oct 31, 2024: 18.4M for, 80K against, 51K abstain.","Total shares present at meeting: 18,521,786 out of 31,711,753 eligible shares (58.4% turnout)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-010995","json":"https://secwatch.observer/filing/0001493152-24-010995.json","markdown":"https://secwatch.observer/filing/0001493152-24-010995.md","text":"https://secwatch.observer/filing/0001493152-24-010995.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/0001493152-24-010995-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:22:10.624868+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0cd02dc00d3c82d67a84a4fb3b5608f62338e1c7","claim":"Anixa Biosciences Inc shareholders approved Approval, by non-binding advisory vote, of the Company's executive compensation at the 2024-03-21 meeting.","evidence_excerpt":"The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 6,010,385 1,843,353 123,415 10,544,633","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/0001493152-24-010995-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-21"}],"fact_type":"shareholder_vote"},{"claim_id":"36b8e66925f53098882b063ec003662913c1b17a","claim":"Anixa Biosciences Inc shareholders approved Ratification of the appointment of independent registered public accounting firm at the 2024-03-21 meeting.","evidence_excerpt":"The voting results were as follows: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Vote 18,390,227 80,392 51,167 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/0001493152-24-010995-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-21"}],"fact_type":"shareholder_vote"},{"claim_id":"69021b5fb13f9825bb6bf82702b0252f421b682c","claim":"Anixa Biosciences Inc shareholders approved Election of directors at the 2024-03-21 meeting.","evidence_excerpt":"The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Vote Dr. Amit Kumar 7,894,499 82,654 10,544,633 Dr. Arnold Baskies 7,857,006 120,147 10,544,633 Emily Gottschalk 7,853,085 124,068 10,544,633 Lewis H. Titterton, Jr. 7,718,162 258,991 10,544,633","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/0001493152-24-010995-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-21"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}